In parallel, CYP substrate drug clearance and expression of the CYP enzymes also change in many of these events, such as obesity (Brill et al., 2012), diabetes (Darakjian et al., 2021), and cancers (Fahy et al., 2012). This evidence concerns the gene PPIG and cancer.